Anne Lesage
Vermogen: 5 M $ op 31-05-2026
Vermogen: 5 M $ op 31-05-2026
Anne Lesage is the founder of GrayMatters Consulting BV, founded in 2010.
Dr. Lesage is the founder of Kosa Pharma GmbH, founded in 2013.
Dr. Lesage is the founder of Pharvaris NV, founded in 2015, holding the title of Chief Early Development Officer since 2015.
Dr. Lesage is the founder of Pharvaris GmbH, founded in 2015, holding the title of Chief Early Development Officer since 2015.
Dr. Lesage completed a doctorate degree at Ghent University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PHARVARIS N.V. 0,22% | 30-06-2026 | 152.719 ( 0,22% ) | 5 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| PHARVARIS N.V. | Oprichter | 30-09-2015 |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Oprichter | 01-10-2015 |
| Bedrijven | Functie | Einde |
|---|---|---|
Kosa Pharma GmbH | Oprichter | - |
GrayMatters Consulting BV | Oprichter | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Ghent University
Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharvaris NV
Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
GrayMatters Consulting BV | |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kosa Pharma GmbH |
Kies jouw editie
Alle financiële informatie op nationaal niveau